AmerisourceBergen

Company Profile

AmerisourceBergen had its IPO on 1995-04-04 under the ticker symbol ABC.

The company operates in the Healthcare sector and Medical Distribution industry. AmerisourceBergen has a staff strength of 39,000 employees.

Stock update

Shares of AmerisourceBergen opened at $176.52 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $174.22 - $177.08, and closed at $174.96.

This is a -0.58% slip from the previous day's closing price.

A total volume of 1,569,808 shares were traded at the close of the day’s session.

In the last one week, shares of AmerisourceBergen have slipped by -2.13%.

AmerisourceBergen's Key Ratios

AmerisourceBergen has a market cap of $30.78 billion, indicating a price to book ratio of 5.5793 and a price to sales ratio of 0.1405.

In the last 12-months AmerisourceBergen’s revenue was $241.81 billion with a gross profit of $8.33 billion and an EBITDA of $3.41 billion. The EBITDA ratio measures AmerisourceBergen's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, AmerisourceBergen’s operating margin was 1.12% while its return on assets stood at 2.94% with a return of equity of 50.2%.

In Q4, AmerisourceBergen’s quarterly earnings growth was a positive 9.4% while revenue growth was a positive 5.4%.

AmerisourceBergen’s PE and PEG Ratio

Forward PE

14.2045

Trailing PE

18.466

PEG

1.5767

Its diluted EPS in the last 12-months stands at $8.24 per share while it has a forward price to earnings multiple of 14.2045 and a PEG multiple of 1.5767. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into AmerisourceBergen’s profitability.

AmerisourceBergen stock is trading at a EV to sales ratio of 0.1497 and a EV to EBITDA ratio of 11.4283. Its price to sales ratio in the trailing 12-months stood at 0.1405.

AmerisourceBergen stock pays annual dividends of $1.865 per share, indicating a yield of 1.27% and a payout ratio of 16.95%.

Balance sheet and cash flow metrics

Total Assets

$57.91 billion

Total Liabilities

$44.76 billion

Operating Cash Flow

$-1511158000.00

Capital Expenditure

$75.73 million

Dividend Payout Ratio

16.95%

AmerisourceBergen ended 2024 with $57.91 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $57.91 billion while shareholder equity stood at $-178131000.00.

AmerisourceBergen ended 2024 with $1.63 billion in deferred long-term liabilities, $44.76 billion in other current liabilities, 2942000.00 in common stock, $3.36 billion in retained earnings and $8.60 billion in goodwill. Its cash balance stood at $1.69 billion and cash and short-term investments were $1.69 billion. The company’s total short-term debt was $988,275,000 while long-term debt stood at $4.66 billion.

AmerisourceBergen’s total current assets stands at $40.71 billion while long-term investments were $0 and short-term investments were $0. Its net receivables were $18.71 billion compared to accounts payable of $41.76 billion and inventory worth $16.78 billion.

In 2024, AmerisourceBergen's operating cash flow was $-1511158000.00 while its capital expenditure stood at $75.73 million.

Comparatively, AmerisourceBergen paid $0.17 in dividends in 2024.

Other key metrics

Current Trading Price

$174.96

52-Week High

$174.0934

52-Week Low

$134.3118

Analyst Target Price

$185

AmerisourceBergen stock is currently trading at $174.96 per share. It touched a 52-week high of $174.0934 and a 52-week low of $174.0934. Analysts tracking the stock have a 12-month average target price of $185.

Its 50-day moving average was $186.62 and 200-day moving average was $169.68 The short ratio stood at 2.1 indicating a short percent outstanding of 0%.

Around 1695.2% of the company’s stock are held by insiders while 7791.7% are held by institutions.